PB1885: PHASE 1 STUDY OF ZIFTOMENIB IN COMBINATION WITH VENETOCLAX, VENETOCLAX/AZACITIDINE, OR STANDARD INDUCTION (7 + 3) CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

• Amer M Zeidan,
• Amir Fathi,
• Ghayas Issa,
• Harry Erba,
• Julie Ahsan Mackey,
• Daniel Corum,
• Blake Tomkinson,
• Tom Kozlek,
• Mollie Leoni,
• Eunice Wang

Affiliations

Amer M Zeidan

1 Yale University, New Haven, United States

Amir Fathi

2 Massachusetts General Hospital, Boston, United States

Ghayas Issa

3 MD Anderson Cancer Center, Houston, United States

Harry Erba

4 Duke University Hospital, Durham, United States

Julie Ahsan Mackey

5 Kura Oncology, Inc, Boston, United States

Daniel Corum

6 Kura Oncology, Inc, Boston, United States

Blake Tomkinson

5 Kura Oncology, Inc, Boston, United States

Tom Kozlek

6 Kura Oncology, Inc, Boston, United States

Mollie Leoni

5 Kura Oncology, Inc, Boston, United States

Eunice Wang

7 Roswell Park Comprehensive Cancer Center, Buffalo, United States